Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: The Turin bundle

New Microbiologica

Volumn 40, Issue 2, 2017, Pages 143-145

  De Rosa, Francesco Giuseppe ^a   Corcione, Silvia ^a   Raviolo, Stefania ^a   Bruno, Benedetto ^b   Busca, Alessandro ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Allogenic haematopoietic stem cell transplant (HSCT); Carbapenem sparing strategies; Carbapenemase producing Klebsiella pneumonia; Decontamination; Mortality.

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; COMBINATION DRUG THERAPY; DRUG EFFECTS; FEMALE; HUMAN; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; STEM CELL TRANSPLANTATION;

ADULT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION;

EID: 85020822148     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Albiger B., Glasner C., Struelens M.J., Grundmann H., Monnet D.L.; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. (2015). Carbapenemase-producing Enterobacteriaceae in Europe: Assessment by national experts from 38 countries, May 2015. Euro Surveill. 20, 49.
2. Bassetti M., Peghin M., Pecori D. (2016). The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis. 29, 583-594.
3. Bucaneve G., Micozzi A., Picardi M., Ballanti S., Cascavilla N., et al. (2014). Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. J Clin Oncol. 32, 1463-1471.
4. Corcione S., Cardellino C.S., Calcagno A., Fossati L., Costa C., et al. (2014). Healthcare-Associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: The time has come. Clin Infect Dis. 59, 321-322.
5. De Rosa F.G., Corcione S., Cavallo R., Di Perri G., Bassetti M. (2015). Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda. Future Microbiol. 10, 283-294.
6. De Rosa F.G., Corcione S., Pagani N., Di Perri G. (2015b). From ESKAPE to ESCAPE, from KPC to CCC. Clin Infect Dis. 60, 1289-1290.
7. European Centre for Disease Prevention and Control. (2015). Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-Tables/v-6.0-Breakpoint-Table.pdf
8. Girmenia C., Viscoli C., Piciocchi A., Cudillo L., Botti S., et al. (2015). Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An Italian multidisciplinary consensus statement. Haematologica. 100, 373-376.
9. Löbbert C., Faucheux S., Becker-Rux D., Laudi S., Dörrbeck A., et al. (2013). Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: A single-centre experience. Int J Antimicrob Agents. 42, 565-570.
10. Pagano L., Caira M., Trecarichi E.M., Spanu T., Di Blasi R., et al. (2014). Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 20, 1235-1236.
11. Tascini C., Sbrana F., Flammini S., Tagliaferri E., Arena F., et. al. (2014). Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother. 58, 1972-1976.
12. Tumbarello M., Trecarichi E.M., De Rosa F.G., Giannella M., Giacobbe D.R., et al. (2015). Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 70, 2133-2143.
13. Oren I., Sprecher H., Finkelstein R., Hadad S., Neuberger A., et al. (2013). Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial. Am. J. Infect. Control. 41, 1167-1172.
14. Saidel-Odes L., Polachek H., Peled N., Riesenberg K., Schlaeffer F., et al. (2012). A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect. Control Hosp. Epidemiol. 33, 14-19.
15. Zuckerman T., Benyamini N., Sprecher H., Fineman R., Finkelstein R., et al. (2011). SCT in patients with carbapenem resistant Klebsiella pneumoniae: A single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transpl. 46, 1226-1230.